Innate Pharma SA
SWB:IDD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
N
|
Novo Nordisk A/S
SWB:NOVA
|
DK |
|
Coro Energy Plc
F:8YY
|
UK |
|
S
|
Scor SE
XMUN:SDRC
|
FR |
|
Abivax SA
OTC:AAVXF
|
FR |
|
C
|
Cirrus Logic Inc
XBER:CRU
|
US |
|
Corero Network Security PLC
LSE:CNS
|
UK |
|
Hermes International SCA
OTC:HESAY
|
FR |
|
A
|
Ambev SA
BMV:ABEVN
|
BR |
|
Kajima Corp
TSE:1812
|
JP |
|
Aligos Therapeutics Inc
F:5WK
|
US |
|
Prospect Capital Corp
NASDAQ:PSEC
|
US |
|
Autodesk Inc
NASDAQ:ADSK
|
US |
|
C
|
Coty Inc
F:CO3A
|
US |
|
A
|
AT & S Austria Technologie & Systemtechnik AG
XHAM:AUS
|
AT |
|
Canopy Growth Corp
TSX:WEED
|
CA |
|
Netflix Inc
NASDAQ:NFLX
|
US |
|
M
|
MSA Safety Inc
SWB:M07
|
US |
|
IHI Corp
OTC:IHICY
|
JP |
|
China Longyuan Power Group Corp Ltd
HKEX:916
|
CN |
|
S
|
Societe Anonyme des Bains de Mer et du Cercle des Etrangers a Monaco SA
LSE:0O80
|
MC |
|
PVR INOX Ltd
BSE:532689
|
IN |
|
E
|
Eagle Materials Inc
SWB:E5M
|
US |
Bankruptcy Probability
Innate Pharma SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Innate Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Innate Pharma SA
PAR:IPH
|
150.3m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
447.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
193.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
158.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Innate Pharma SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Innate Pharma SA has total debt of 13.8m EUR. This includes both short-term (0 EUR) and long-term (13.8m EUR) debt.
You can find a full breakdown on its Balance Sheet.
